Statins have no role in pulmonary disease mortality [5]

Chest

Volumn 132, Issue 4, 2007, Pages 1408-

  Vos, Eddie ^a   Mascitelli, Luca ^b,c  

^a Sutton Que   (Canada)

^b Comando Brigata Alpina Julia ^*

^c Sanitary Service   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; EZETIMIBE PLUS SIMVASTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PLACEBO;

AVIAN INFLUENZA; CHOLESTEROL BLOOD LEVEL; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; DISEASE ASSOCIATION; DRUG EFFECT; DRUG EFFICACY; DYSLIPIDEMIA; HUMAN; INFLUENZA; LETTER; LUNG DISEASE; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; RISK REDUCTION; UPPER RESPIRATORY TRACT INFECTION;

EID: 35448996096     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.07-1157     Document Type: Article

References (7)

1. Frost FJ, Petersen H, Tollestrup K, et al. Influenza and COPD mortality protection as pleiotropic, dose-dependent effects of statins. Chest 2007; 131:1006-1012
2. Mancini GB. Clarion call for trials assessing "cardiopulmonary" agents to reduce morbidity and mortality in inflammatory lung diseases. Chest 2007; 131:950-951
3. Iribarren C, Jacobs DR Jr, Sidney S, et al. Serum total cholesterol and risk of hospitalization, and death from respiratory disease. Int J Epidemiol 1997; 26:1191-1202
4. Vytorin prescribing information, Table 8. Available at: http://www.vytorin.com/vytorin/shared/documents/vytorin_pi.pdf. Accessed May 11, 2007
5. Heart Protection Study Collaborators Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomized placebo-control trial. Lancet 2002; 360:7-22
6. Matsuzaki M, Kita T, Mabuchi H, et al. Large scale cohort study of the relationship between serum cholesterol concentration and coronary events with low-dose simvastatin therapy in Japanese patients with hypercholesterolemia. Circ J 2002; 66:1087-1095
7. Ulmer H, Kelleher C, Diem G, et al. Why Eve is not Adam: prospective follow-up in 149,650 women and men of cholesterol and other risk factors related to cardiovascular and all-cause mortality. J Womens Health 2004; 13:41-53